Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction

Hypertension
Jian-Yong QianMargot C LaPointe

Abstract

We have shown previously that cyclooxygenase-2 inhibition reduces cardiac hypertrophy and fibrosis postmyocardial infarction (MI) in a mouse model and that prostaglandin E(2) stimulates cardiomyocyte hypertrophy in vitro through its EP(4) receptor. Because the role of cardiac myocyte EP(4) in cardiac function and hypertrophy in vivo is unknown, we generated mice lacking EP(4) only in cardiomyocytes (CM- EP(4) knockout [KO]). Twelve- to 14-week-old mice were evaluated using echocardiography and histology. There were no differences in ejection fraction, myocyte cross-sectional area, and interstitial collagen fraction between KO mice and littermate controls. To test the hypothesis that EP(4) is involved in cardiac remodeling after MI, we induced MI by ligating the left anterior descending coronary artery. Two weeks later, the mice were subjected to echocardiography, and hearts were removed for histology and Western blot. There was no difference in infarct size between KO mice and controls; however, KO mice showed less myocyte cross-sectional area and interstitial collagen fraction than controls. Also, CM-EP4 KO mice had reduced ejection fraction. Because the transcription factor Stat-3 is involved in hypertrophy and protection fro...Continue Reading

References

May 23, 1998·Annual Review of Pharmacology and Toxicology·J R VaneR M Botting
May 26, 1998·Biochemical and Biophysical Research Communications·E SegiA Ichikawa
Oct 3, 1999·Physiological Reviews·S NarumiyaF Ushikubi
Jun 17, 2000·Progress in Lipid Research·Y SugimotoA Ichikawa
Dec 26, 2001·Hypertension·I DukaH Gavras
Jan 29, 2002·Journal of Molecular and Cellular Cardiology·Nicole ScheurenWinfried Schorb
Mar 8, 2002·Hypertension·Mariela Mendez, Margot C LaPointe
Jun 11, 2002·British Journal of Pharmacology·Takayuki FujinoFumitaka Ushikubi
Jul 10, 2002·Circulation·Bertram PittJames T Willerson
Oct 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jörg J JacobyXin-Yuan Fu
Dec 13, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Margot C LaPointeXiao-Ping Yang
Sep 9, 2004·Genesis : the Journal of Genetics and Development·André SchneiderMatthew D Breyer
Jan 1, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Mariela Mendez, Margot C LaPointe
Mar 15, 2005·The Journal of Clinical Investigation·Gerald W Dorn, Thomas Force
Jun 21, 2005·Pharmacology & Therapeutics·Denise Hilfiker-KleinerHelmut Drexler
Oct 6, 2005·Molecular Pharmacology·Hiromichi Fujino, John W Regan
Jan 24, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Jian-Yong QianMargot C LaPointe
Jan 31, 2006·Lancet·Lionel H OpieMarc A Pfeffer
Dec 13, 2006·Cardiovascular Research·Marcus C Schaub, Martin A Hefti
Jan 5, 2007·Proceedings of the National Academy of Sciences of the United States of America·Julie R McMullenGarry L Jennings
Jan 31, 2007·Hypertension·William B White

❮ Previous
Next ❯

Citations

Apr 21, 2009·Proceedings of the National Academy of Sciences of the United States of America·Dairong WangGarret A FitzGerald
Jun 24, 2008·Cardiovascular Research·Miguel A FriasUrsula Lang
Nov 21, 2008·Cardiovascular Research·Jutta Meyer-KirchrathThomas Hohlfeld
Nov 3, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Quan HeMargot C LaPointe
Dec 17, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Pamela HardingMargot C LaPointe
Jan 5, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Pamela HardingMargot C Lapointe
Dec 20, 2008·Journal of Lipid Research·Emer M SmythGarret A FitzGerald
Jul 26, 2011·Journal of Cell Communication and Signaling·David B MurrayJoseph S Janicki
Feb 12, 2015·Journal of Proteome Research·Ning LiHuiru Tang
Sep 3, 2011·Clinical and Translational Science·Risto KerkeläThomas Force
May 7, 2015·Experimental Physiology·Xiaosong GuPamela Harding
Jul 27, 2010·Progress in Lipid Research·Melanie J Stables, Derek W Gilroy
Sep 7, 2016·Oxidative Medicine and Cellular Longevity·Guangrui Yang, Lihong Chen
Apr 21, 2016·Journal of Cardiovascular Pharmacology and Therapeutics·Shuang LiuJianhua Zhu
Aug 10, 2016·Circulation. Heart Failure·Xiaosong GuPamela Harding
Jun 17, 2018·EMBO Molecular Medicine·András D TóthJohannes Backs
Jun 19, 2013·Pharmacological Reviews·Utako YokoyamaYoshihiro Ishikawa
Aug 15, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yin CaiEva Hoi-Ching Tang
Nov 13, 2018·Circulation Journal : Official Journal of the Japanese Circulation Society·Toshiki SakumaSusumu Minamisawa
Mar 7, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Timothy D BrysonPamela Harding
Oct 30, 2018·Journal of the American Heart Association·Jasmine M F WuPatrick C H Hsieh
Apr 17, 2021·American Journal of Physiology. Heart and Circulatory Physiology·Matthew D MartensJoseph W Gordon
Nov 14, 2016·Microbiology Spectrum·Melanie Bennett, Derek W Gilroy
Jul 27, 2021·Frontiers in Physiology·Gustavo Jose Justo da SilvaAlessandro Cataliotti
Nov 26, 2021·Biochemical Pharmacology·Timothy D Bryson, Pamela Harding

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.